Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (944)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
167
Price
$534.30
Total Value
$89.23K
Shares Held After
332,361
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
215
Price
$533.14
Total Value
$114.63K
Shares Held After
332,528
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$531.94
Total Value
$170.22K
Shares Held After
332,743
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$530.13
Total Value
$127.23K
Shares Held After
333,063
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$528.72
Total Value
$190.34K
Shares Held After
333,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$527.90
Total Value
$147.81K
Shares Held After
333,663
% of Holdings
0.1%
Alignment Healthcare, Inc. (ALHC)
Kim Hyong — Chief Medical Officer
Shares
32,479
Price
$8.30
Total Value
$269.58K
Shares Held After
299,271
% of Holdings
9.8%
Artiva Biotherapeutics, Inc. (ARTV)
Aslan Fred — Director
Shares
23,463
Price
$7.20
Total Value
$168.88K
Shares Held After
1,519,606
% of Holdings
1.5%
Medline Inc. (MDLN)
GIC Private Ltd — 10% Owner
Shares
7,183,013
Price
$35.05
Total Value
$251.76M
Shares Held After
77,225,493
% of Holdings
8.5%
Medline Inc. (MDLN)
GIC Private Ltd — 10% Owner
Shares
2,088,987
Price
$35.05
Total Value
$73.22M
Shares Held After
16,453,806
% of Holdings
11.3%
MeiraGTx Holdings plc (MGTX)
Naylor Stuart — CHIEF SCI OFCR, OPHTHALMOLOGY
Shares
27,659
Price
$10.64
Total Value
$294.29K
Shares Held After
613,187
% of Holdings
4.3%
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
CTT PHARMACEUTICAL HOLDINGS, INC. — Director
Shares
3,700
Price
$0.06
Total Value
$203.50
Shares Held After
9,433,656
% of Holdings
0.0%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
4,166
Price
$55.07
Total Value
$229.41K
Shares Held After
43,381
% of Holdings
8.8%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
21,000
Price
$96.81
Total Value
$2.03M
Shares Held After
87,209
% of Holdings
19.4%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$61.38
Total Value
$214.83K
Shares Held After
153,902
% of Holdings
2.2%
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Parisotto Shannon M — CEVP, Disc&Safety Assessment
Shares
981
Price
$308.44
Total Value
$302.58K
Shares Held After
4,807
% of Holdings
16.9%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
312
Price
$165.60
Total Value
$51.67K
Shares Held After
69,291
% of Holdings
0.4%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
327
Price
$164.78
Total Value
$53.88K
Shares Held After
69,603
% of Holdings
0.5%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
888
Price
$163.93
Total Value
$145.57K
Shares Held After
69,930
% of Holdings
1.3%
BillionToOne, Inc. (BLLN)
ten Bosch John Roderick — SVP of Laboratory Operations
Shares
1,417
Price
$105.15
Total Value
$149.00K
Shares Held After
19,385
% of Holdings
6.8%
BillionToOne, Inc. (BLLN)
ten Bosch John Roderick — SVP of Laboratory Operations
Shares
1,417
Price
$105.15
Total Value
$149.00K
Shares Held After
20,802
% of Holdings
6.4%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
100
Price
$110.09
Total Value
$11.01K
Shares Held After
1,000
% of Holdings
9.1%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
1,829
Price
$109.14
Total Value
$199.63K
Shares Held After
1,100
% of Holdings
62.4%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
4,916
Price
$108.53
Total Value
$533.55K
Shares Held After
2,929
% of Holdings
62.7%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
2,200
Price
$107.47
Total Value
$236.44K
Shares Held After
7,845
% of Holdings
21.9%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
400
Price
$106.10
Total Value
$42.44K
Shares Held After
10,045
% of Holdings
3.8%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
555
Price
$105.56
Total Value
$58.59K
Shares Held After
10,445
% of Holdings
5.0%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
20
Price
$110.08
Total Value
$2.20K
Shares Held After
11,000
% of Holdings
0.2%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
2,921
Price
$109.00
Total Value
$318.40K
Shares Held After
11,020
% of Holdings
21.0%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
4,284
Price
$108.39
Total Value
$464.36K
Shares Held After
13,941
% of Holdings
23.5%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
1,909
Price
$107.19
Total Value
$204.64K
Shares Held After
18,225
% of Holdings
9.5%
BillionToOne, Inc. (BLLN)
Tsao David — Director
Shares
866
Price
$105.90
Total Value
$91.71K
Shares Held After
20,134
% of Holdings
4.1%
GRAIL, Inc. (GRAL)
Partridge Andrew John — Chief Growth Officer
Shares
7,873
Price
$146.39
Total Value
$1.15M
Shares Held After
155,865
% of Holdings
4.8%
GRAIL, Inc. (GRAL)
Freidin Aaron — Chief Financial Officer
Shares
23,619
Price
$146.39
Total Value
$3.46M
Shares Held After
225,364
% of Holdings
9.5%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
272
Price
$13.61
Total Value
$3.70K
Shares Held After
709,153
% of Holdings
0.0%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
58,061
Price
$12.92
Total Value
$750.24K
Shares Held After
709,425
% of Holdings
7.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,638
Price
$64.03
Total Value
$104.88K
Shares Held After
105,272
% of Holdings
1.5%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
2,403
Price
$15.00
Total Value
$36.05K
Shares Held After
49,448
% of Holdings
4.6%
Acrivon Therapeutics, Inc. (ACRV)
Miller Mary — Chief Legal Officer
Shares
294
Price
$1.99
Total Value
$585.06
Shares Held After
81,715
% of Holdings
0.4%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
2,718
Price
$35.57
Total Value
$96.67K
Shares Held After
6,832
% of Holdings
28.5%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
3,198
Price
$35.57
Total Value
$113.74K
Shares Held After
8,038
% of Holdings
28.5%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
8,580
Price
$35.57
Total Value
$305.16K
Shares Held After
21,064
% of Holdings
28.9%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
45
Price
$207.46
Total Value
$9.34K
Shares Held After
562,760
% of Holdings
0.0%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
146
Price
$206.84
Total Value
$30.20K
Shares Held After
562,805
% of Holdings
0.0%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
297
Price
$205.78
Total Value
$61.12K
Shares Held After
562,951
% of Holdings
0.1%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
290
Price
$204.80
Total Value
$59.39K
Shares Held After
563,248
% of Holdings
0.1%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
432
Price
$203.61
Total Value
$87.96K
Shares Held After
563,538
% of Holdings
0.1%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
1,017
Price
$202.32
Total Value
$205.76K
Shares Held After
563,970
% of Holdings
0.2%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
481
Price
$201.26
Total Value
$96.80K
Shares Held After
564,987
% of Holdings
0.1%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
1,840
Price
$200.44
Total Value
$368.81K
Shares Held After
565,468
% of Holdings
0.3%
944 transactions